Nutranomics Inc
OTC:NNRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nutranomics Inc
OTC:NNRX
|
US |
|
M
|
Metrod Holdings Bhd
KLSE:METROD
|
MY |
|
G
|
Guangdong Redwall New Materials Co Ltd
SZSE:002809
|
CN |
|
Group Eleven Resources Corp
XTSX:ZNG
|
CA |
|
D
|
Defense Technologies International Corp
OTC:DTII
|
US |
|
M
|
MJ Harvest Inc
OTC:MJHI
|
US |
|
H
|
HeNan Splendor Science & Technology Co Ltd
SZSE:002296
|
CN |
|
InterMetro Communications Inc
OTC:IMTO
|
US |
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
|
F
|
Filament Health Corp
NEO:FH
|
CA |
Discount Rate
NNRX Cost of Equity
Discount Rate
NNRX's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 8.13%.
The Beta, indicating the stock's volatility relative to the market, is 0.91, while the current Risk-Free Rate, based on government bond yields, is 4.32%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
What is NNRX's discount rate?
NNRX
's current Cost of Equity is 8.13%.
In the valuation of banks and insurance companies, only the cost of equity is used due to their unique capital structures and regulatory environments.
These institutions heavily rely on debt, regulated more stringently than other industries, making the Weighted Average Cost of Capital (WACC) less applicable and accurate for them. The cost of equity offers a more direct measure of the risk and return expectations relevant to these specific sectors.
How is Cost of Equity for NNRX calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
NNRX
